Youth involvement in local pharmaceutical manufacturing in sub-Saharan Africa: barriers, recommendations, and public health implications

Background: In 2021, Africa imported 99% of its vaccines and 70% of its pharmaceuticals. As such, there has been a growing concern about and acknowledgement of the need for Africa to produce its own medicines. There are, however, only 375 pharmaceutical manufacturers in Africa, most of which are in North Africa, leaving a dearth in sub-Saharan Africa. Despite the youthful population of sub-Saharan Africa, with 33% of its population between the ages of 10 and 35, youth are not actively involved in pharmaceutical manufacturing. This commentary explores the barriers to and opportunities for youth inclusion in sub-Saharan Africa’s local manufacturing of pharmaceutical products. Methods: This commentary synthesises findings from existing literature and case studies of youth engagement in local pharmaceutical manufacturing. It also explores current regional policies relevant to youth involvement in the local manufacturing of pharmaceutical products in sub-Saharan Africa. Results: Several barriers hinder the involvement of youth in local pharmaceutical manufacturing, including a lack of financial capacity among young persons, inadequate training and mentorship, and regulatory hurdles. In addition, policy frameworks from key stakeholders like the WHO rarely include plans for youth involvement in local manufacturing. Conclusion: Youth participation in local manufacturing is important for the growth of the pharmaceutical industry in sub-Saharan Africa and for achieving local self-sufficiency in medicine and vaccines. Future policy revisions should explicitly prioritise youth inclusion in pharmaceutical manufacturing across the region, steps should be taken to promote industry-academia collaborations, and incubation hubs for youth-led pharmaceutical startups should be established. These efforts will enable the region to maximise its demographic advantage and achieve sustainable local pharmaceutical manufacturing.

Authors

Institutions

Publication Details

Journal
INNOVATIONS in pharmacy
Published
2026-01-15
DOI
https://doi.org/10.24926/iip.v16i4.6778
Primary Topic
Innovation and Socioeconomic Development
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Youth involvement in local pharmaceutical manufacturing in sub-Saharan Africa: barriers, recommendations, and public health implications

Oluwaseyi Muyiwa Egbewande, O.E. Okediji, Yusuf Babatunde
INNOVATIONS in pharmacy
Innovation and Socioeconomic Development
article

Youth involvement in local pharmaceutical manufacturing in sub-Saharan Africa: barriers, recommendations, and public health implications

Oluwaseyi Muyiwa Egbewande, O.E. Okediji, Yusuf Babatunde
article en

Abstract

Background: In 2021, Africa imported 99% of its vaccines and 70% of its pharmaceuticals. As such, there has been a growing concern about and acknowledgement of the need for Africa to produce its own medicines. There are, however, only 375 pharmaceutical manufacturers in Africa, most of which are in North Africa, leaving a dearth in sub-Saharan Africa. Despite the youthful population of sub-Saharan Africa, with 33% of its population between the ages of 10 and 35, youth are not actively involved in pharmaceutical manufacturing. This commentary explores the barriers to and opportunities for youth inclusion in sub-Saharan Africa’s local manufacturing of pharmaceutical products. Methods: This commentary synthesises findings from existing literature and case studies of youth engagement in local pharmaceutical manufacturing. It also explores current regional policies relevant to youth involvement in the local manufacturing of pharmaceutical products in sub-Saharan Africa. Results: Several barriers hinder the involvement of youth in local pharmaceutical manufacturing, including a lack of financial capacity among young persons, inadequate training and mentorship, and regulatory hurdles. In addition, policy frameworks from key stakeholders like the WHO rarely include plans for youth involvement in local manufacturing. Conclusion: Youth participation in local manufacturing is important for the growth of the pharmaceutical industry in sub-Saharan Africa and for achieving local self-sufficiency in medicine and vaccines. Future policy revisions should explicitly prioritise youth inclusion in pharmaceutical manufacturing across the region, steps should be taken to promote industry-academia collaborations, and incubation hubs for youth-led pharmaceutical startups should be established. These efforts will enable the region to maximise its demographic advantage and achieve sustainable local pharmaceutical manufacturing.

INNOVATIONS in pharmacyVol. 16(4)
University of Ilorin (NG)
Openalex Percentile: Top 88%
Innovation and Socioeconomic Development
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.